Flex Opens New Product Introduction (NPI) Center Serving Healthcare Customers in North America

News Summary

  • New NPI center offers a complete end-to-end product development solution from prototype to preclinical builds to design verification and production transfer
  • Located near Boston, Mass., in proximity to one of the world’s largest medical technology innovation hubs
  • Featuring a full suite of design for excellence (DfX) services to ensure product design preparedness for manufacturing across a broad range of factors

AUSTIN, Texas, March 20, 2025 /PRNewswire/ — Flex (NASDAQ: FLEX) today announced the opening of its new product introduction (NPI) center near Boston, Mass., serving healthcare customers. The center serves as a gateway to manufacturing, supporting end-to-end product development from prototype to preclinical builds, design verification and production transfer helping customers get their products to market faster, at scale, and with less risk.

“Our new NPI center offers healthcare customers in North America a truly integrated, design-led manufacturing solution that ensures a seamless transition from prototype to product launch,” said Kate Benedict, President, Health Solutions Business, Flex. “This expansion builds on existing NPI capabilities in Flex’s healthcare sites around the world, further strengthening the end-to-end, vertically integrated solutions that customers rely on to deliver products at scale with increased quality, productivity, and speed.”

The new NPI center supports customers in surgical robotics, medical devices, medical technology systems, imaging equipment, and lab diagnostic equipment, among a wide array of other healthcare products. The center features an 8,000 sq. ft. NPI lab capable of running several lines simultaneously, and a 2,000 sq. ft. quality and design validation testing lab.

Featuring Flex’s world-class quality management system for healthcare, the center will enable customers to meet the most stringent compliance standards regulated medical products. The center is expected to be ISO13485 certified by Q2 calendar year 2025.

The new NPI center joins Flex’s global footprint of approximately 100 sites, enabling seamless movement between design and manufacturing facilities across and within regions. With the ability to partner at any point of the product lifecycle, Flex helps healthcare companies navigate increasing complexity across the value chain to design, build, deliver, and service medical products that transform patient care.

About Flex
Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets.

Media & Press
Christie Haber
Director, Commercial Marketing
602-245-1057
christie.haber@flex.com 

Investors & Analysts
David A. Rubin
Vice President, Investor Relations
(408) 577-4632
David.Rubin@flex.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/flex-opens-new-product-introduction-npi-center-serving-healthcare-customers-in-north-america-302406422.html

SOURCE Flex

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

1 hour ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

1 hour ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

1 hour ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

4 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

4 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

4 hours ago